Chinese medicine bureau: a Chinese medicine pilot found that the effective rate of new crown pneumonia reached 90percent

category:Society
 Chinese medicine bureau: a Chinese medicine pilot found that the effective rate of new crown pneumonia reached 90percent


According to the official website, on January 27, the State Administration of traditional Chinese medicine, guided by clinical emergency utility, launched the special project of screening and Research on effective prescriptions of traditional Chinese medicine for the prevention and treatment of pneumonia caused by new coronavirus infection in an emergency manner, and carried out the clinical efficacy observation of Qingfei Paidu Decoction for the treatment of pneumonia caused by new coronavirus infection in Shanxi, Hebei, Heilongjiang and Shaanxi provinces, focusing on the observation of confirmed patients Symptoms such as asthenia, fever, cough, sore throat, poor appetite and changes in imaging performance are aimed at quickly finding the core prescription with good curative effect and even special effect for this epidemic.

According to statistics, as of 0:00 on February 5, 214 cases were treated with Qingfei Paidu Decoction in four pilot provinces, three days as a course of treatment, with a total effective rate of more than 90%, of which more than 60% of the patients showed significant improvement in symptoms and imaging performance, and 30% of the patients showed stable and no aggravation.

According to the official website, according to experts, Qingfei Paidu decoction is an optimized combination of several classical prescriptions in Treatise on Febrile Diseases and miscellaneous diseases written by Zhang Zhongjing of Han Dynasty to treat exogenous fever caused by pathogenic cold. It is reasonable in composition and mild in nature. It can be used to treat mild, common and severe pneumonia patients with new coronavirus infection. It can also be combined with the actual situation of patients in the treatment of critical patients Reasonable use of the situation. It can also be used in patients with the common cold and flu. However, it is a prescription for disease treatment and is not recommended to be used as a prophylactic.

Zhang Boli, member of the expert group of the National Health Commission, academician of the Chinese Academy of engineering and President of Tianjin University of traditional Chinese medicine, introduced that for the moderate and mild patients with new pneumonia, it is easy to recover after the treatment of traditional Chinese medicine, and the transformation from the moderate to the severe is significantly reduced; for the severe and critical patients, it can stabilize the blood oxygen saturation, improve the dyspnea, and have a certain auxiliary treatment effect; it has a certain effect on the recovery Although there is no infectivity in the convalescent patients, they can be discharged from the hospital. In the later stage, they are treated with traditional Chinese medicine to avoid some sequelae.